-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Da2jiXzAGQewB91kaQS5+KxdhBPtBK1rqmtqlOEdHAXg3B0GT/V/aS8tfS99eRmo cGWseEXXQUmeY6ICaQsonQ== 0001104659-03-025827.txt : 20031112 0001104659-03-025827.hdr.sgml : 20031112 20031112163422 ACCESSION NUMBER: 0001104659-03-025827 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031105 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20031112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON BIOMEDICA INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 03994340 BUSINESS ADDRESS: STREET 1: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801900 MAIL ADDRESS: STREET 1: 375 WEST ST CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 8-K 1 a03-5255_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

 

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 5, 2003

 

 

Boston Biomedica, Inc.

(Exact Name Of Registrant As Specified In Its Charter)

 

 

 

Massachusetts

(State or Other Jurisdiction of Incorporation)

 

 

 

0-21615

 

04-2652826

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

 

 

375 West Street, West Bridgewater, MA

 

02379-1040

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

(508) 580-1900

(Registrant’s Telephone Number, Including Area Code)

 

 

 

N/A

 (Former Name or Former Address, if Changed Since Last Report)

 

 

 

Item 4.             Changes in Registrant’s Certifying Accountant.

 

(b)  Engagement of New Independent Accountant.

 

                On November 5, 2003, the Audit Committee of the Board of Directors of Boston Biomedica, Inc. (the “Company”), engaged Weinberg & Company P.A. (“Weinberg & Company”) to act as the Company’s independent accountants for the remainder of fiscal 2003, effective immediately.

 

                During the fiscal years ended December 31, 2001 and December 31, 2002 and through the date hereof, neither the Company nor anyone on its behalf consulted with Weinberg & Company with respect to any matters or events, including any matters or events set forth and described in Items 304(a)(2)(i) and (ii) of Regulation S-K.

 

SIGNATURES

 

                Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 12, 2003

BOSTON BIOMEDICA, INC.

 

 

 

 

 

By:  /s/ Kevin W. Quinlan

 

Kevin W. Quinlan, President, Chief Operating Officer and Treasurer

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----